Four-year variation in pathogen distribution and antimicrobial susceptibility of urosepsis: a single-center retrospective analysis
Therapeutic Advances in Infectious Disease · 2024-01 · 11
DOI: 10.1177/20499361241248058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Infectious Disease, online erschienen am 26.04.2024. Verfasst von Yu-Yun Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P. R. China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Yunnan Provincial Science and Technology Department Zhangqun Ye Expert’s Workstation, Yunnan Provincial Science and Technology Department/ Yunnan Medical Science Specialist Training Project.
Abstract (Originalsprache)
Background
Urosepsis is a common disease in urology, which is characterized by high treatment costs and high mortality. In the treatment of sepsis, anti-infection therapy is the most important means. However, the effect of empirical anti-infection therapy is often not ideal. Therefore, it is necessary to continuously monitor the prevalence of bacterial isolates in the blood culture of patients with urinary sepsis and their sensitivity to antibacterial drugs. This is of great significance to improve the efficacy of empirical antibiotic therapy for urosepsis.
Objective
To elucidate the landscape of prevailing bacterial profiles and their antimicrobial susceptibilities in urosepsis cases, and to furnish robust clinical evidence to underpin the timely initiation of empirical antibiotic treatment.
Methods
Collect the basic information and blood culture results of patients with urosepsis hospitalized from 2017 to 2020. Retrospective analysis of bacterial species and antimicrobial susceptibility in urosepsis and changes over 4 years.
Results
Gram-negative bacteria (178 isolates, 75.11%) constituted the main pathogens causing urosepsis, followed by Gram-positive bacteria (46 isolates, 19.41%) and fungus (13 isolates, 5.48%). The sensitivity of ertapenem, meropenem, amikacin, and imipenem to Gram-negative bacteria all exceeded 85%. The sensitivity rates of levofloxacin, gentamicin, and ciprofloxacin are decreasing every year ( p < 0.05). Tigecycline, vancomycin, and linezolid exhibited excellent sensitivity against Gram-positive bacteria. Among fungi, fluconazole demonstrated universal sensitivity, while itraconazole-resistant isolates have been found, and amphotericin B is still effective.
Conclusion
Analysis of blood culture results of patients more accurately reflected the etiology of urosepsis, mainly Escherichia coli, Enterococcus, and Klebsiella pneumoniae. If there are no definitive blood culture results, empiric treatment of urosepsis should not include fluoroquinolone antibiotics. Cefepime, cefoxitin, and ceftazidime are the most sensitive antibiotics to Gram-negative bacteria besides carbapenem antibiotics. In addition, the current situation regarding extended-spectrum β-lactamase-producing bacteria and carbapenem-resistant Enterobacteriaceae bacteria resistance is extremely concerning with limited therapeutic options available. Strengthening antibiotic management practices and exploring novel antibacterial agents can help mitigate this issue.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P. R. China.
- The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 374 Dian-Mian Avenue, Kunming, Yunnan, 650101, P. R. China.
ORCID-Profile: Jiong-Ming Li
Förderung
- Yunnan Provincial Science and Technology Department Zhangqun Ye Expert’s Workstation
- Yunnan Provincial Science and Technology Department/ Yunnan Medical Science Specialist Training Project
Zitieren
APA
Wu, Y. Y., Li, P., Huang, Z. Y., Liu, J. H., Yang, B. W., Zhou, W. B., Duan, F., Wang, G., & Li, J. M. (2024). Four-year variation in pathogen distribution and antimicrobial susceptibility of urosepsis: a single-center retrospective analysis. Therapeutic Advances in Infectious Disease, 11. https://doi.org/10.1177/20499361241248058
Vancouver
Wu YY, Li P, Huang ZY, Liu JH, Yang BW, Zhou WB, et al. Four-year variation in pathogen distribution and antimicrobial susceptibility of urosepsis: a single-center retrospective analysis. Therapeutic Advances in Infectious Disease. 2024;11. doi:10.1177/20499361241248058
BibTeX
@article{Wu2024,
author = {Wu, Yu-Yun and Li, Pei and Huang, Zi-Ye and Liu, Jian-He and Yang, Bo-Wei and Zhou, Wen-Bo and Duan, Fei and Wang, Guang and Li, Jiong-Ming},
title = {Four-year variation in pathogen distribution and antimicrobial susceptibility of urosepsis: a single-center retrospective analysis},
journal = {Therapeutic Advances in Infectious Disease},
year = {2024},
volume = {11},
doi = {10.1177/20499361241248058}
}
EUVIMED